참고문헌
- Al-Suhaimi E. Molecular mechanisms of leptin and pro-apoptotic signals induced by menadione in HepG2 cells. Saudi J Biol Sci. 2014; 21:582-588. https://doi.org/10.1016/j.sjbs.2014.03.002
- Hassan GS. Menadione. Profiles Drug Subst Excip Relat Methodol. 2013;38:227-313. https://doi.org/10.1016/B978-0-12-407691-4.00006-X
- Kim YJ, Shin YK, Sohn DS, Lee CS. Menadione induces the formation of reactive oxygen species and depletion of GSH-mediated apoptosis and inhibits the FAK-mediated cell invasion. Naunyn Schmiedebergs Arch Pharmacol. 2014;387:799-809. https://doi.org/10.1007/s00210-014-0997-x
- Osada S, Tomita H, Tanaka Y, Tokuyama Y, Tanaka H, Sakashita F, et al. The utility of vitamin K3 (menadione) against pancreatic cancer. Anticancer Res. 2008;28:45-50.
- Oztopcu-Vatan P, Sayitoglu M, Gunindi M, Inan E. Cytotoxic and apoptotic effects of menadione on rat hepatocellular carcinoma cells. Cytotechnology. 2015;67:1003-1009. https://doi.org/10.1007/s10616-014-9739-7
- Tetef M, Margolin K, Ahn C, Akman S, Chow W, Leong L, et al. Mitomycin C and menadione for the treatment of lung cancer: a phase II trial. Invest New Drugs. 1995;13:157-162. https://doi.org/10.1007/BF00872865
- Igney FH, Krammer PH. Death and anti-death: tumour resistance to apoptosis. Nat Rev Cancer. 2002;2:277-288. https://doi.org/10.1038/nrc776
- Li MX, Dewson G. Mitochondria and apoptosis: emerging concepts. F1000Prime Rep. 2015;7:42. https://doi.org/10.12703/p7-42
- De Almagro MC, Vucic D. The inhibitor of apoptosis (IAP) proteins are critical regulators of signaling pathways and targets for anti-cancer therapy. Exp Oncol. 2012;34:200-211.
- Span PN, Tjan-Heijnen VC, Heuvel JJ, de Kok JB, Foekens JA, Sweep FC. Do the survivin (BIRC5) splice variants modulate or add to the prognostic value of total survivin in breast cancer? Clin Chem. 2006;52:1693-1700. https://doi.org/10.1373/clinchem.2006.071613
- Chantalat L, Skoufias DA, Kleman JP, Jung B, Dideberg O, Margolis RL. Crystal structure of human survivin reveals a bow tie-shaped dimer with two unusual alpha-helical extensions. Mol Cell. 2000;6:183-189. https://doi.org/10.1016/S1097-2765(05)00020-1
- Sah NK, Khan Z, Khan GJ, Bisen PS. Structural, functional and therapeutic biology of survivin. Cancer Lett. 2006;244:164-171. https://doi.org/10.1016/j.canlet.2006.03.007
- Chen X, Duan N, Zhang C, Zhang W. Survivin and tumorigenesis: molecular mechanisms and therapeutic strategies. J Cancer. 2016;7:314-323. https://doi.org/10.7150/jca.13332
- Mobahat M, Narendran A, Riabowol K. Survivin as a preferential target for cancer therapy. Int J Mol Sci. 2014;15:2494-2516. https://doi.org/10.3390/ijms15022494
- Tang C, Lu YH, Xie JH, Wang F, Zou JN, Yang JS, et al. Downregulation of survivin and activation of caspase-3 through the PI3K/Akt pathway in ursolic acid-induced HepG2 cell apoptosis. Anticancer Drugs. 2009;20:249-258. https://doi.org/10.1097/CAD.0b013e328327d476
- Altieri DC, Marchisio PC. Survivin apoptosis: an interloper between cell death and cell proliferation in cancer. Lab Invest. 1999;79:1327-1333.
- Li F, Ambrosini G, Chu EY, Plescia J, Tognin S, Marchisio PC, et al. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature. 1998;396:580-584. https://doi.org/10.1038/25141
- Lee MH, Yang JY, Cho Y, Park M, Woo HJ, Kim HW, et al. Menadione induces apoptosis in a gastric cancer cell line mediated by down-regulation of X-linked inhibitor of apoptosis. Int J Clin Exp Med. 2016;9:2437-2443.
- Siegel RL, Miller KD, Jemal A. Cancer statistics. CA Cancer J Clin. 2016;66:7-30. https://doi.org/10.3322/caac.21332
- Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87-108. https://doi.org/10.3322/caac.21262
- Romero-Gallo J, Harris EJ, Krishna U, Washington MK, Perez-Perez GI, Peek RM Jr. Effect of Helicobacter pylori eradication on gastric carcinogenesis. Lab Invest. 2008;88:328-336. https://doi.org/10.1038/labinvest.3700719
- Tariq M, Al Moutaery A. Menadione protects gastric mucosa against ethanol-induced ulcers. Exp Toxicol Pathol. 2005;56:393-399. https://doi.org/10.1016/j.etp.2004.12.003
- Li F, Altieri DC. Transcriptional analysis of human survivin gene expression. Biochem J. 1999;344(Pt 2):305-311. https://doi.org/10.1042/bj3440305
- Esteve PO, Chin HG, Pradhan S. Molecular mechanisms of transactivation and doxorubicin-mediated repression of survivin gene in cancer cells. J Biol Chem. 2007;282:2615-2625. https://doi.org/10.1074/jbc.M606203200
- Gritsko T, Williams A, Turkson J, Kaneko S, Bowman T, Huang M, et al. Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells. Clin Cancer Res. 2006;12:11-19. https://doi.org/10.1158/1078-0432.CCR-04-1752
- Lee MH, Cho Y, Kim DH, Woo HJ, Yang JY, Kwon HJ, et al. Menadione induces G2/M arrest in gastric cancer cells by down-regulation of CDC25C and proteasome mediated degradation of CDK1 and cyclin B1. Am J Transl Res. 2016;8:5246-5255.